145 related articles for article (PubMed ID: 30501133)
1.
Vue B; Zhang S; Vignau A; Chen G; Zhang X; Diaz W; Zhang Q; Zheng S; Wang G; Chen QH
Molecules; 2018 Nov; 23(12):. PubMed ID: 30501133
[TBL] [Abstract][Full Text] [Related]
2. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
[TBL] [Abstract][Full Text] [Related]
3. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
[TBL] [Abstract][Full Text] [Related]
4. 7-O-aminoalkyl-2,3-dehydrosilibinins: Synthesis and in vitro Anti-cancer Efficacy.
Ma DY; Zhang LC; Peng KJ; Zeng J; Liu LJ; Luo ZY; Liu SY
Anticancer Agents Med Chem; 2018; 18(8):1156-1162. PubMed ID: 29607789
[TBL] [Abstract][Full Text] [Related]
5. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.
Zhang S; Vue B; Huang M; Zhang X; Lee T; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3226-3231. PubMed ID: 27261177
[TBL] [Abstract][Full Text] [Related]
6. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422
[TBL] [Abstract][Full Text] [Related]
7. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
Li X; Lee M; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4768-4777. PubMed ID: 28760528
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models.
Rajaram P; Jiang Z; Chen G; Rivera A; Phasakda A; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Chem; 2019 Jun; 87():227-239. PubMed ID: 30904813
[TBL] [Abstract][Full Text] [Related]
9. 3-
Wu S; Chen G; Zhang Q; Wang G; Chen QH
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770829
[TBL] [Abstract][Full Text] [Related]
10. Core Structure-Activity Relationship Studies of 5,7,20-
Wu S; Chen G; Chen EY; Farshidpour LS; Zhang Q; Wang G; Chen QH
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111288
[TBL] [Abstract][Full Text] [Related]
11. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells.
Mantena SK; Sharma SD; Katiyar SK
Mol Cancer Ther; 2006 Feb; 5(2):296-308. PubMed ID: 16505103
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship.
Agarwal C; Wadhwa R; Deep G; Biedermann D; Gažák R; Křen V; Agarwal R
PLoS One; 2013; 8(3):e60074. PubMed ID: 23555889
[TBL] [Abstract][Full Text] [Related]
13. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
14. Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations.
Romanucci V; Agarwal C; Agarwal R; Pannecouque C; Iuliano M; De Tommaso G; Caruso T; Di Fabio G; Zarrelli A
Bioorg Chem; 2018 Apr; 77():349-359. PubMed ID: 29421711
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
[TBL] [Abstract][Full Text] [Related]
17. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
Flaig TW; Su LJ; Harrison G; Agarwal R; Glodé LM
Int J Cancer; 2007 May; 120(9):2028-33. PubMed ID: 17230508
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
Li X; Zhang C; Guo S; Rajaram P; Lee M; Chen G; Fong R; Gonzalez A; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2018 Sep; 157():978-993. PubMed ID: 30165345
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
